Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - Cardiff Oncology, Inc. | a12-2660_1ex32d1.htm |
EX-31.2 - EX-31.2 - Cardiff Oncology, Inc. | a12-2660_1ex31d2.htm |
10-K - 10-K - Cardiff Oncology, Inc. | a12-2660_110k.htm |
EX-32.2 - EX-32.2 - Cardiff Oncology, Inc. | a12-2660_1ex32d2.htm |
Exhibit 31.1
CERTIFICATION
I, Antonius Schuh, certify that:
1. I have reviewed this annual report on Form 10-K of Trovagene, Inc. (the Registrant);
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;
4. The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
b. Not applicable.
c. Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d. Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
March 30, 2012 |
/s/ANTONIUS SCHUH |
|
|
|
Antonius Schuh |
|
Chief Executive Officer |